Lastly, a systematic review and meta-analysis specifically evaluating the role of the HER2/HER3 pathway in CCA described different prevalences of HER2 overexpression in Asian patients (28.4%) compared with Western ones (19.7%) [56]. This evidence concerns the gene ERBB2 and cholangiocarcinoma.